ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $67,638,000 | +456.8% | 601,066 | +371.4% | 0.85% | +397.1% |
| Q2 2020 | $12,147,000 | -47.5% | 127,500 | -50.5% | 0.17% | -56.0% |
| Q1 2020 | $23,146,000 | +306.1% | 257,549 | +139.6% | 0.39% | +380.2% |
| Q4 2019 | $5,700,000 | -2.3% | 107,500 | -37.4% | 0.08% | +17.4% |
| Q2 2014 | $5,836,000 | -90.9% | 171,800 | -90.8% | 0.07% | -91.3% |
| Q1 2014 | $64,439,000 | -23.2% | 1,867,800 | -11.8% | 0.79% | -35.7% |
| Q4 2013 | $83,859,000 | – | 2,117,648 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
| Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
| Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
| QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
| Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
| WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
| EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
| Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |